Background, approaches and recent trends for setting health-based occupational exposure limits: A minireview

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 3, 2008, Pages 253-269

  Nielsen, Gunnar Damgård ^a   Øvrebø, Steinar ^b  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^b NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

MAK; Maximale Arbeitsplatz Koncentration; Occupational exposure limits; Risk assessment; Threshold Limit Values; TLV; Toxicology

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; COLCHICINE; DNA TOPOISOMERASE INHIBITOR; FORMALDEHYDE; PACLITAXEL; VINYL ACETATE;

ARTICLE; CARCINOGENICITY; EPIGENETICS; EUROPEAN UNION; GENOTOXICITY; GERMANY; HUMAN; JAPAN; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN ABSORPTION; STANDARD; TOXICITY TESTING; TOXICOKINETICS; UNITED STATES; WORKPLACE; WORKROOM AIR;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; CHEMICAL INDUSTRY; HUMANS; MAXIMUM ALLOWABLE CONCENTRATION; MUTAGENS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; THRESHOLD LIMIT VALUES;

EID: 47749118345     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.04.002     Document Type: Article

References (192)

1. Acheson E.D., Cowdell R.H., Hadfield E., and Macbeth R.G. Nasal cancer in woodworkers in the furniture industry. Br. Med. J. 2 5605 (1968) 587-596
2. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 72 (2006) 1605-1621
3. Alessio L., Campagna M., and Lucchini R. From lead to manganese through mercury: mythology, science, and lessons for prevention. Am. J. Ind. Med. 50 (2007) 779-787
4. American Conference of Governmental Industrial Hygienists (ACGIH), 2007. TLVs and BEIs. Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. ACGIH, Cincinnati.
5. Appel K.-E., Bernauer U., Herbst U., Madle S., Schulte A., Richter-Reichhelm H.-B., and Gundert-Remy U. Kann für Formaldehyde eine,, sichere" Koncentration abgeleitet werden? Analyse der Daten zur krebserzeugenden Wirkung. Umweltmed. Forsch. Prax. 11 (2006) 347-361
6. Aprea C., Sciarra G., Lunghini L., Centi L., and Ceccarelli F. Evaluation of respiratory and cutaneous doses and urinary excretion of alkylphosphates by workers in greenhouses treated with Omethoate, Fenitrothion, and Tolclofos-Methyl. AIHAJ 62 (2001) 87-95
7. Arts J.H.E., Mommers C., and de Heer C. Dose-response relationships and threshold levels in skin and respiratory allergy. Crit. Rev. Toxicol. 36 (2006) 219-251
8. Au W.W., Lee E., and Christiani D.C. Biomarker research in occupational health. J. Occup. Environ. Med. 47 (2005) 145-153
9. Azad N., Rojanasakul Y., and Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J. Toxicol. Environ. Health B 11 (2008) 1-15
10. Baker D.J., Dawlaty M.M., Galardy P., and van Deursen J.M. Mitotic regulation of the anaphase-promoting complex. Cell. Mol. Life Sci. 64 (2007) 589-600
11. Bartek J., and Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 490 (2001) 117-122
12. Bartek J., and Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell. Biol. 19 (2007) 238-245
13. Battershill J.M. The multiple chemicals and actions model of carcinogenesis. A possible new approach to developing prevention strategies for environmental carcinogenesis. Hum. Exp. Toxicol. 24 (2005) 547-558
14. Baur X. Are we close to developing threshold limit values for allergens in the workplace?. Ann. Allergy Asthma Immunol. 90 Suppl. 2 (2003) 11-18
15. Baur X., Chen Z., and Liebers V. Exposure-response relationships of occupational inhalative allergens. Clin. Exp. Allergy 28 (1998) 537-544
16. Bello D., Herrick C.A., Smith T.J., Woskie S.R., Streicher R.P., Cullen M.R., Liu Y., and Redlich C.A. Skin exposure to isocyanates: reasons for concern. Environ. Health Perspect. 115 (2007) 328-335
17. Bello D., Woskie S.R., Streicher R.P., Liu Y., Stowe M.H., Eisen E.A., Ellenbecker M.J., Sparer J., Youngs F., Cullen M.R., and Redlich C.A. Polyisocyantaes in occupational environments: a critical review of exposure limits and metrics. Am. J. Ind. Med. 46 (2004) 480-491
18. Bingham E., and Grimsley L.F. Regulations and guidelines in the workplace. In: Bingham E., Cohrssen B., and Powell C.H. (Eds). Patty's Toxicology. fifth ed. vol. 1 (2001), John Wiley and Sons, New York 321-352
19. Bingham E., and Zapp J. Industrial toxicology: origin and trends. In: Bingham E., Cohrssen B., and Powell C.H. (Eds). Patty's Toxicology. Fifth ed. vol. 1 (2001), John Wiley and Sons, New York 1-16
20. Bogdanffy M.S., and Valentine R. Differentiating between local cytotoxicity, mitogenesis, and genotoxicity in carcinogen risk assessments: the case of vinyl acetate. Toxicol. Lett. 140-141 (2003) 83-98
21. Bolon B. Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research. Basic Clin. Pharmacol. Toxicol. 95 (2004) 154-161
22. Bolt H.M. Genotoxicity-threshold or not? Introduction of cases of industrial chemicals. Toxicol. Lett. 140-141 (2003) 43-51
23. Bolt H.M., and Degen G.H. carcinogenic risk evaluation. Part II: Contributions of the EUROTOX specialty section for carcinogenesis. Toxicol. Sci. 81 (2004) 3-6
24. Bolt H.M., Foth H., Hengstler J.G., and Degen G.H. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Toxicol. Lett. 151 (2004) 29-41
25. Bolt H.M., and Their R. Biological monitoring and Biological Limit Values (BLV): the strategy of the European Union. Toxicol. Lett. 162 (2006) 119-124
26. Boobis A.R., Cohen S.M., Dellarco V., McGregor D., Meek M.E., Vickers C., Willcocks D., and Farland W. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36 (2006) 781-792
27. Boogaard P.J., Denneman M.A., and van Sittert N.J. Dermal penetration and metabolism of five glycidyl ethers in human, rat and mouse skin. Xenobiotica 30 (2000) 469-483
28. Branzei D., and Foiani M. Interplay of replication checkpoints and repair proteins at stalled replication forks. DNA Repair 6 (2007) 994-1003
29. Binks S.P. Occupational toxicology and the control of exposure to pharmaceutical agents at work. Occup. Med. 53 (2003) 363-370
30. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70 (2001) 369-413
31. Cheeseman M.A. Thresholds as a unifying theme in regulatory toxicology. Food Addit. Contam. 22 (2005) 900-906
32. 50 as a criterion for skin notation. Appl. Occup. Environ. Hyg. 18 (2003) 154-155
33. Cherrie J.W. The beginning of the science underpinning occupational hygiene. Ann. Occup. Hyg. 47 (2003) 179-185
34. Christmann M., Tomicic M.T., Roos W.P., and Kaina B. Mechanisms of human DNA repair: an update. Toxicology 193 (2003) 3-34
35. Clayton, G.D., 1992. Frank A. Patty. Am. Ind. Hyg. Assoc. J. 53, A74-A75.
36. Clewell R.A., and Clewell H.J. Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regul. Toxicol. Pharmacol. 50 (2008) 129-143
37. Cogliano V.J., Baan R.A., Straif K., Grosse Y., Secretan M.B., Ghissassi F.E., and Kleihues P. The science and practice of carcinogen identification and evaluation. Environ. Health Perspect. 112 (2004) 1269-1274
38. Cohen H.J. 2007 Donald E. Cummings Memorial Award Lecture. The industrial hygiene profession: current and future issues. J. Occup. Environ. Hyg. 5 (2008) D43-D47
39. Conolly R.B., Kimbell J.S., Janszen D., Schlosser P.M., Kalisak D., Preston J., and Miller F.J. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Toxicol. Sci. 75 (2003) 432-447
40. Conolly R.B., Kimbell J.S., Janszen D., Schlosser P.M., Kalisak D., Preston J., and Miller F.J. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci. 82 (2004) 279-296
41. Corbett K.D., and Berger J.M. Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 95-118
42. Cross H.J., Faux S.P., and Levy L.S. Establishing an occupational exposure limit for hexavalent chromium in the European Union. Regul. Toxicol. Pharmacol. 26 (1997) S72-S76
43. Crump K.S., Hoel D.G., Langley C.H., and Peto R. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36 (1976) 2973-2979
44. Culver B.D. Herbert E. Stokinger award lecture 2005-innovation for the TLV process. J. Occup. Environ. Hyg. 2 (2005) D70-D73
45. Czerczak S., and Kupczewska M. Assignment of skin notation for maximum allowable concentration (MAC) list in Poland. Appl. Occup. Environ. Hyg. 17 (2002) 187-199
46. De Cock J., Heederik D., Kromhout H., and Boleij J.S.M. Strategy for assigning a "skin notation": a comment. Ann. Occup. Hyg. 40 (1996) 611-614
47. Dennison J.E., Bigelow P.L., Mumtaz M.M., Anderson M.E., Dobrev I.D., and Yang R.S.H. Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling. J. Occup. Environ. Hyg. 2 (2005) 127-135
48. Deutsche Forschungsgemeinschaft-Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (DFG), 2006a. List of MAK and BAT values 2006. Wiley-VCH, Weinheim.
49. Deutsche Forschungsgemeinschaft-Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe (DFG), 2006b. Toxikologisch-arbeitsmedizinische Begründung von MAK-Werten. Wiley-VCH, Weinheim.
50. Dolan D.G., Naumann B.D., Sargent E.V., Maier A., and Dourson M. Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations. Regul. Toxicol. Pharmacol. 43 (2005) 1-9
51. Dorne J.L.C.M. Human variability in hepatic and renal elimination: implications for risk assessment. J. Appl. Toxicol. 27 (2007) 411-420
52. Dorne J.L.C.M., and Renwick A.G. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol. Sci. 86 (2005) 20-26
53. Dourson M.L., Andersen M.E., Erdreich L.S., and MacGregor J.A. Using human data to protect the public's health. Regul. Toxicol. Pharmacol. 33 (2001) 234-256
54. Dourson M.L., Felter S.P., and Robinson D. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 24 (1996) 108-120
55. Drexler H. Assignment of skin notation for MAK values and its legal consequences in Germany. Int. Arch. Occup. Environ. Health 71 (1998) 503-505
56. Drexler H. Skin protection and percutaneous absorption of chemical hazards. Int. Arch. Occup. Environ. Health 76 (2003) 359-361
57. Droz P.O., and Fiserova-Bergerova V. Biological monitoring. VI: Pharmacokinetic models used in setting biological exposure indices. Appl. Occup. Environ Hyg. 7 (1992) 574-580
58. Dybing E. Development and implementation of the IPCS conceptual framework for evaluating mode of action of chemical carcinogens. Toxicology 181-182 (2002) 121-125
59. El-Masri H. Experimental and mathematical modeling methods for the investigation of toxicological interactions. Toxicol. Appl. Pharmacol. 223 (2007) 148-154
60. Ettinger H.J. Henry Smith Jr. Award Lecture-occupational exposure limits: do we need them? Who is responsible? How do we get them?. J. Occup. Environ. Hyg. 2 (2005) D25-D30
61. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), 2002. Guidance on evaluation of reproductive toxicity data, Monograph No. 31. ECETOC, Brussels, ISSN-0773-6347-31.
62. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), 2006. Guidance for setting occupational limits: emphasis on data-poor substances, Technical Report No. 101. ECETOC, Brussels, ISSN-0773-8072-101.
63. European Commission (EC), 1995. 95/320/EC: Commission Decision of 12 July 1995 setting up a Scientific Committee for Occupational Exposure Limits to Chemical Agents. Official Journal of the European Union L 188, 9.8.1995, pp. 14-15.
64. European Commission (EC), 1999. Methodology for the derivation of occupational exposure limits: Key documentation. European Commission, Directorate-General for Employment, Industrial Relations and Social Affairs, Luxembourg, ISBN 92-828-8106-7.
65. European Commission (EC). Health & Consumer Protection Directorate-General, 2004. Guidance Document on Dermal Absorption. Sanco/222/2000 rev. 7, 19 March 2004. Available at: (accessed October 9, 2007).
66. European Commission (EC), 2006. Commission Decision of 10 April 2006, amending Decision 95/320/EC setting up a Scientific Committee for Occupational Exposure Limits to Chemical Agents. Official Journal of the European Union L 101, 11.4.2006, p. 4.
67. European Council Directive (ECD), 1998. Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work (fourteenth individual directive within the meaning of Article 16(1) of Directive 89/391/EEC). Official Journal of the European Union L 131, 5.5.1998, pp. 11-23.
68. European Council Directive (ECD), 2004. Corrigendum to Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (sixth individual directive within the meaning of Article 16(1) of Council Directive 89/391/EEC). Official Journal of the European Union L 229, 29.6.2004, pp. 23-34.
69. European Parliament and Council Regulation (EPCR), 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemical Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union L 396, 30.12.2006, pp. 1-849. Available at: .
70. Fairhurst S. The uncertainty factor in the setting of occupational exposure standards. Ann. Occup. Hyg. 39 (1995) 375-385
71. Fairhurst S. Hazard and risk assessment of industrial chemicals in the occupational context in Europe: some current issues. Food Chem. Toxicol. 41 (2003) 1453-1462
72. Feron V.J., Arts J.H.E., and Mojet J. Approach to setting occupational exposure limits for sensory irritants in the Netherlands. AIHAJ 62 (2001) 733-735
73. Fiserova-Bergerova V., Pierce J.T., and Droz P.O. Dermal absorption potential of industrial chemicals: criteria for skin notation. Am. J. Ind. Med. 17 (1990) 617-635
74. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N. Engl. J. Med. 345 (2001) 1890-1900
75. Foth H., Degen G.H., and Bolt H.M. New aspects in the classification of carcinogens. Arh. Hig. Rada. Toksikol. 56 (2005) 165-173
76. Fustinoni S., Marcadante R., Campo L., Scibetta L., Valla C., Consonni D., and Foa V. Comparison between urinary o-cresol and toluene as biomarkers of toluene exposure. J. Occup. Environ. Hyg. 4 (2007) 1-9
77. Franks S.J. A mathematical model for the absorption and metabolism of formaldehyde vapour by humans. Toxicol. Appl. Pharmacol. 206 (2005) 309-320
78. Gaffney S.H., and Paustenbach D.J. A proposed approach for setting occupational exposure limits for sensory irritants based on chemosensory models. Ann. Occup. Hyg. 51 (2007) 345-356
79. Gardner M.K., and Odde D.J. Modeling of chromosome motility during mitosis. Curr. Opin. Cell Biol. 18 (2006) 639-647
80. Geinoz S., Guy R.H., Testa B., and Carrupt P.-A. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm. Res. 21 (2004) 83-92
81. Gigant B., Wang C., Ravelli R.B.G., Roussi F., Steinmetz M.O., Curmi P.A., Sobel A., and Knossow M. Structural basis for the regulation of tubulin by vinblastine. Nature 435 (2005) 519-522
82. Gochfeld M. Chronologic history of occupational medicine. J. Occup. Environ. Med. 47 (2005) 96-114
83. Gochfeld M. Occupational medicine practice in the United States since the industrial revolution. J. Occup. Environ. Med. 47 (2005) 115-131
84. Gold L.S., Gaylor D.W., and Slone T.H. Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regul. Toxicol. Pharmacol. 37 (2003) 45-53
85. Greim H. Grenzwerte der DFG-Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Gerfahrstoffe Reinhalt Luft 63 (2003) 175-180
86. Greim H., and Reuter U. Classification of carcinogenic chemicals in the work area by the German MAK Commission: current examples for the new categories. Toxicology 166 (2001) 11-23
87. Grosse Y., Baan R., Straif K., Secretan B., El Ghissassi F., Bouvard V., Altieri A., and Cogliano V. Carcinogenicity of 1,3-butadiene, ethylene oxide, vinyl chloride, vinyl fluoride, and vinyl bromide. Lancet Oncol. 8 (2007) 679-680
88. Guess H.A., and Crump K.S. Best-estimate low-dose extrapolation of carcinogenicity data. Environ. Health Perspect. 22 (1978) 149-152
89. Haber L.T., Maier A., Gentry P.R., Clewell H.J., and Dourson M.L. Genetic polymorphisms in assessing interindividual variability in delivered dose. Regul. Toxicol. Pharmacol. 35 (2002) 177-197
90. Haber L.T., Maier A., Zhao Q., Dollarhide J.S., Savage R.E., and Dourson M.L. Application of mechanistic data in risk assessment: the past, present, and future. Toxicol. Sci. 61 (2001) 32-39
91. Hansson S.O. Critical effects and exposure limits. Risk Anal. 17 (1997) 227-236
92. Hartwig A., and Schwerdtle T. Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications. Toxicol. Lett. 127 (2002) 47-54
93. Hatch T.F. Permissible levels of exposure to hazardous agents in industry. J. Occup. Med. 14 (1972) 134-137
94. Hatch T.F. The role of permissible limits for hazardous airborne substances in the working environment in the prevention of occupational disease. Bull. World Health Organ. 47 (1972) 151-159
95. Hemelt M., Granström C., and Hemminki K. Occupational risks for nasal cancer in Sweden. J. Occup. Environ. Med. 46 (2004) 1033-1040
96. Henschler D. Exposure limits: history, philosophy, future developments. Ann. Occup. Hyg. 28 (1984) 79-92
97. Henschler D. Development of occupational limits in Europe. Ann. Am. Conf. Ind. Hyg. 12 (1985) 37-40
98. Henschler D. Evaluation of adverse effects in the standard-setting process. Toxicol. Lett. 64/65 (1992) 53-57
99. Heron R.J.L., and Pickering F.C. Health effects of exposure to active pharmaceutical ingredients (APIs). Occup. Med. 53 (2003) 357-362
100. Hewett P. Mean testing. I. Advantages and disadvantages. Appl. Occup. Environ. Hyg. 12 (1997) 339-346
101. Hunter W.J., Aresini G., Haigh R., Papadopoulos P., and von der Hude W. Occupational exposure limits for chemicals in the European Union. Occup. Environ. Med. 54 (1997) 217-222
102. International Programme on Chemical Safety (IPCS)-INCHEM-Chemical Safety Information from Intergovernmental Organizations. Available at: (accessed 31.7.2007).
103. Interdepartmental Group on Health Risks from Chemicals (IGHRC), 2003. Uncertainty factors: Their use in human health risk assessment by UK government. MRC Institute for Environmental and Health, University of Leicester. Available at: (accessed 24.7.2007).
104. Jahnke G.D., Choksi N.Y., Moore J.A., and Shelby M.D. Thyroid toxicants: assessing reproductive health effects. Environ. Health Perspect. 112 (2004) 363-368
105. Jayjock M.A., Lewis P.G., and Lynch J.R. Quantitative level of protection offered to workers by ACGIH threshold limit values occupational exposure limits. AIHAJ 62 (2001) 4-11
106. Jones K., Garfitt S., Emms V., Warren N., Cocker J., and Farmer P. Correlation of haemoglobin-acrylamide adducts with airborne exposures: an occupational survey. Toxicol. Lett. 162 (2006) 174-180
107. Kakkar P., and Jaffery F.N. Biological markers for metal toxicity. Environ. Toxicol. Pharmacol. 19 (2005) 335-349
108. Kirsch-Volders M., Aardema M., and Elhajouji A. Concepts of threshold in mutagenesis and carcinogenesis. Mutat. Res. 464 (2000) 3-11
109. Kirsch-Volders M., Vanhauwaert A., and Eichenlaub-Ritter U. Decordier. I. Indirect mechanisms of genotoxicity. Toxicol. Lett. (2003) 63-74
110. Kolanz M.E. Introduction to beryllium: uses, regulatory history, and disease. Appl. Occup. Environ. Hyg. 16 (2001) 559-567
111. Kristiansson M.H., Lindh C.H., and Jönsson B.A.G. Correlations between air levels of hexahydrophthalic anhydride (HHPA) and HHPA-adducted albumin tryptic peptides in nasal lavage fluid from experimentally exposed volunteers. Rapid Commun. Mass Spectrom. 18 (2004) 1592-1598
112. Kupczewska-Dobecka M., and Czerczak S. The skin notation in the MAC list and classification of dangerous chemicals. Int. J. Occup. Med. Environ. Health 19 (2006) 84-91
113. Leung H.-W., and Paustenbach D.J. Application of pharmacokinetics to derive biological exposure indexes from Threshold Limit Values. Am. Ind. Hyg. Assoc. J. 49 (1988) 445-450
114. Levine S.P. 2006 Donald E. Cummings Memorial Award Lecture. Industrial hygiene: the founders, the pioneers, and the next generation. J. Occup. Environ. Hyg. 3 (2006) D102-D109
115. Li G.-Y., Lee H.-Y., Shin H.-S., Kim H.-Y., Lim C.-H., and Lee B.-H. Identification of gene markers for formaldehyde exposure in humans. Environ. Health Perspect. 115 (2007) 1460-1466
116. Liang Y., Wong O., Yang L., Li T., and Su Z. The development and regulation of occupational exposure limits in China. Regul. Toxicol. Pharmacol. 46 (2006) 107-113
117. Lutz W.K. Differences in individual susceptibility to toxic effects of chemicals determine the dose-response relationship and consequences of setting exposure standards. Toxicol. Lett. 126 (2002) 155-158
118. Luxon S.G. A history of industrial hygiene. Am. Ind. Hyg. Assoc. J. 45 (1984) 731-739
119. Lynch A., Harvey J., Aylott M., Nicholas E., Burman M., Siddiqui A., Walker S., and Rees R. Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis 18 (2003) 345-353
120. Madl A.K., Unice K., Brown J.L., Kolanz M.E., and Kent M.S. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant. J. Occup. Environ. Hyg. 4 (2007) 448-466
121. Malmanche N., Maia A., and Sunkel C.E. The spindle assembly checkpoint: preventing chromosome mis-segregation during mitosis and meiosis. FEBS Lett. 580 (2006) 2888-2895
122. Mattes W.B., Pettit S.D., Sansone S.-A., Bushel P.R., and Waters M.D. Database development in toxicogenomics: issues and efforts. Environ. Health Perspect. 112 (2004) 495-505
123. May K.M., and Hardwick K.G. The spindle checkpoint. J. Cell Sci. 119 (2006) 4139-4142
124. McCarty L.S., and Borgert C.J. Review of the toxicity of chemical mixtures: theory, policy, and regulatory practice. Regul. Toxicol. Pharmacol. 45 (2006) 119-143
125. McCunney R.J. Asthma, genes, and air pollution. J. Occup. Environ. Med. 47 (2005) 1285-1291
126. Meldrum M. Setting occupational exposure limits for sensory irritants: the approach in the European Union. AIHAJ 62 (2001) 730-732
127. Moody R.P., and MacPherson H. Determination of dermal absorption QSAR/QSPRs by brute force regression: multiparameter model development with molsuite 2000. J. Toxicol. Environ Health A 66 (2003) 1927-1942
128. Moolgavkar S.H., and Luebeck G. Two-event model for carcinogenesis: biological, mathematical, and statistical considerations. Risk Anal. 10 (1990) 323-341
129. Moss G.P., Dearden J.C., Patel H., and Cronin M.T.D. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. In Vitro 16 (2002) 299-317
130. Mumtaz M.M., Ruiz P., and de Rosa C.T. Toxicity assessment of unintentional exposure to multiple chemicals. Toxicol. Appl. Pharmacol. 223 (2007) 104-113
131. National Toxicology Program (NTP), U.S. Department of Health and Human Services. Report on Carcinogens, 11th. Web page last updated May10, 2007. Available at: (accessed 31.7.2007).
132. Naumann B.D., and Sargent E.V. Setting occupational exposure limits for pharmaceuticals. Occup. Med. State of the Art Reviews 12 (1997) 67-80
133. Naya M., and Nakanishi J. Risk assessment of formaldehyde for the general population in Japan. Regul. Toxicol. Pharmacol. 43 (2005) 232-248
134. Nielsen G.D., Hansen J.S., Lund R.M., Bergqvist M., Larsen S.T., Clausen S.K., Thygesen P., and Poulsen O.M. IgE-mediated asthma and rhinitis. I: A role of allergen exposure?. Pharmacol. Toxicol. 90 (2002) 231-242
135. Nielsen G.D., Wolkoff P., and Alarie Y. Sensory irritation: risk assessment approaches. Regul. Toxicol. Pharmacol. 48 (2007) 6-18
136. Nielsen G.D., Olsen O., Larsen S.T., Løvik M., Poulsen L.K., Glue C., Brandorff N.P., and Nielsen P.J. IgE-mediated sensitisation, rhinitis and asthma from occupational exposures. Smoking as a model for airborne adjuvants?. Toxicology 216 (2005) 87-105
137. Nielsen J.B., and Andersen H.R. Cholinesterase activity in female greenhouse workers-influence of work practices and use of oral contraceptives. J. Occup. Health 44 (2002) 234-239
138. Nielsen J.B., and Grandjean P. Criteria for skin notation in different countries. Am. J. Ind. Med. 45 (2004) 275-280
139. Noisel N., Bouchard M., and Carrier G. Evaluation of the health impact of lowering the formaldehyde occupational exposure limit for Quebec workers. Regul. Toxicol. Pharmacol. 48 (2007) 118-127
140. Omae K.(C.). Recommendation of occupational exposure limits (2006-2007). J. Occup. Health 48 (2006) 290-306
141. Omae K., Takebayashi T., and Sakurai H. Occupational exposure limits based on biological monitoring: the Japan Society for Occupational Health. Int. Arch. Occup. Environ. Health 72 (1999) 271-273
142. Pacchierotti F., and Ranaldi R. Mechanisms and risk of chemically induced aneuploidy in mammalian germ cells. Curr. Pharm. Des. 12 (2006) 1489-1504
143. Paustenbach D.J. Occupational exposure limits. Encyclopaedia of Occupational Health and Safety. fourth ed. vol. 1 (1998), International Labour Office, Geneva 30.27-30.32
144. Paustenbach D.J. Health risk assessment and the practice of industrial hygiene. Am. Ind. Hyg. Assoc. J. 51 (1990) 339-351
145. Paustenbach D.J. The history and biological basis of occupational exposure limits for chemical agents. In: Harris R.L. (Ed). Patty's Industrial Hygiene. fifth ed. vol. 3 (2000), John Wiley and Sons, New York 1903-2000
146. Paustenbach D., and Galbraith D. Biomonitoring: is body burden relevant to public health?. Regul. Toxicol. Pharmacol. 44 (2006) 249-261
147. Paustenbach D., and Langner R. Corporate occupational exposure limits: the current state of affairs. Am. Ind. Hyg. Assoc. J. 47 (1986) 809-818
148. Paustenbach D.J., Madl A.K., and Greene J.F. Identifying an appropriate occupational exposure limit (OEL) for beryllium: data gaps and current research initiatives. Appl. Occup. Environ. Hyg. 16 (2001) 527-538
149. Pohl H.R., Luukinen B., and Holler J.S. Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effects. Regul. Toxicol. Pharmacol. 42 (2005) 209-217
150. Pratt I.S., and Barron T. Regulatory recognition of indirect genotoxicity mechanisms in the European Union. Toxicol. Lett. 140-141 (2003) 53-62
151. Rappaport S.M. Threshold limit values, permissible exposure limits, and feasibility: the bases for exposure limits in the United States. Am. J. Ind. Med. 23 (1993) 683-694
152. Reuter U., Heinrich-Hirsch B., Hellwig J., Holzum B., and Welsch F. Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test). Regul. Toxicol. Pharmacol. 38 (2003) 17-26
153. Roach S.A., and Rappaport S.M. But they are not thresholds: a critical analysis of the documentation of Threshold Limit Values. Am. J. Ind. Med. 17 (1990) 727-753
154. Roberts R.A., Crump K.S., Lutz W.K., Wiegand H.-J., Williams G.M., Harrison P.T.C., and Purchase I.F.H. Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation. Arch. Toxicol. 75 (2001) 507-512
155. Rodricks J.V. 2006 American College of Toxicology Distinguished Service Award Lecture: has quantitative risk assessment been of benefit to the science of toxicology?. Int. J. Toxicol. 26 (2007) 3-12
156. Rossman M.D. Chronic beryllium disease: a hypersensitivity disorder. Appl. Occup. Environ. Hyg. 16 (2001) 615-618
157. Sanner T., and Dybing E. Comparison of carcinogen hazard characterisation based on animal studies and epidemiology. Basic Clin. Pharmacol. Toxicol. 96 (2005) 66-70
158. Sanner T., and Dybing E. Comparison of carcinogenic and in vivo genotoxic potency estimates. Basic Clin. Pharmacol. Toxicol. 96 (2005) 131-139
159. Sanner T., Dybing E., Willems M.I., and Kroese E.D. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25. Pharmacol. Toxicol. 88 (2001) 331-341
160. Sargent E.V., and Kirk G.D. Establishing airborne exposure control limits in the pharmaceutical industry. Am. Ind. Hyg. Assoc. J. 49 (1988) 309-313
161. Sartorelli P. Dermal exposure assessment in occupational medicine. Occup. Med. 52 (2002) 151-156
162. Schakelford R.E., Kaufmann W.K., and Paules R.S. Oxidative stress and cell cycle checkpoint function. Free Radic. Biol. Med. 28 (2000) 1387-1404
163. Schenk L., Hansson S.O., Rudén C., and Gilek M. Occupational exposure limits: a comparative study. Regul. Toxicol. Pharmacol. 50 (2008) 261-270
164. Schneider K., Schuhmacher-Wolz U., Hassauer M., Darschnik S., Elmshäuser E., and Mosbach-Schulz O. A probabilistic effect assessment model for hazardous substances at the workplace. Regul. Toxicol. Pharmacol. 44 (2006) 172-181
165. Schoeffler A.J., and Berger J.M. Recent advances in understanding structure-function relationships in the type II topoisomerase mechanism. Biochem. Soc. Trans. 33 (2005) 1465-1470
166. Schulte P.A. The contributions of genetics and genomics to occupational safety and health. Occup. Environ. Med. 64 (2007) 717-718
167. Scientific Committee (SC). Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. Request No EFSA-Q-2004-020, adopted on 18 October 2005. EFSA J. 282 (2005) 1-31. http://www.efsa.europa.eu/etc/medialib/efsa/science/sc_commitee/sc_opinions/1201.Par.0002.File.dat/sc_op_ej282_gentox_en3.pdf Available at: (accessed August 22, 2007)
168. Seeley M.R., Tonner-Navarro L.E., Beck B.D., Deskin R., Feron V.J., Johanson G., and Bolt H.M. Procedures for health risk assessment in Europe. Regul. Toxicol. Pharmacol. 34 (2001) 153-169
169. Siemiatycki J., Richardson L., Straif K., Latreille B., Lakhani R., Campbell S., Rousseau M.-C., and Boffetta P. Listing occupational carcinogens. Environ. Health Perspect. 112 (2004) 1447-1459
170. Smyth H.F. The toxicological basis of Threshold Limit Values. 1. Experience with Threshold limit values based on animal data. Am. Ind. Hyg. Assoc. J. 20 (1959) 341-345
171. Spirtas R., Fleming L.E., Demers P.A., and Weisburger E.K. TLV carcinogenicity categories: recent modifications. Appl. Occup. Environ. Hyg. 16 (2001) 875-883
172. Steinke J.W., Rich S.S., and Borish L. Genetics of allergic disease. J. Allergy Clin. Immunol. 121 (2008) S384-S387
173. Stokinger H.E. Concepts of thresholds in standard setting. An analysis of the concept and its application to industrial air limits (TLVs). Arch. Environ. Health 25 (1972) 153-157
174. Subramaniam R.P., Crump K.S., van Landingham C., White P., Chen C., and Schlosser P.M. Uncertainties in the CIIT model for formaldehyde-induced carcinogenicity in the rat: a limited sensitivity analysis. I. Risk Anal. 27 (2007) 1237-1253
175. Takahashi K., and Higashi T. The development and regulation of occupational exposure limits in Japan. Regul. Toxicol. Pharmacol. 46 (2006) 120-125
176. Teuschler L.K. Deciding which chemical mixtures risk assessment methods work best for what mixtures. Toxicol. Appl. Pharmacol. 223 (2007) 139-147
177. Their R., and Bolt H.M. European aspects of standard setting in occupational hygiene and medicine. Rev. Environ. Health 16 (2001) 81-86
178. Topping M. Occupational exposure limits for chemicals. Occup. Environ. Med. 58 (2001) 138-144
179. Travis K.Z., Pate I., and Welsh Z.K. The role of the benchmark dose in a regulatory context. Regul. Toxicol. Pharmacol. 43 (2005) 280-291
180. Truchon G., Tardif R., Droz P.-O., Charest-Tardif G., and Pierrehumbert G. Biological exposure indicators: quantification of biological variability using toxicokinetic modeling. J. Occup. Environ. Hyg. 3 (2006) 137-143
181. Vainiotalo S., Riihimäki V., Pekari K., Teräväinen E., and Aito A. Toxicokinetics of methyl tert-butyl ether (MTBE) and tert-amyl methyl ether (TAME) in humans, and implications to their biological monitoring. J. Occup. Environ. Hyg. 4 (2007) 739-750
182. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006) 1-40
183. van den Oever R. Occupational exposure to dust and sinonasal cancer. An analysis of 386 cases reported to the N.C.C.S.F. cancer registry. Acta Otorhinolaryngol. Belg. 50 (1996) 19-24
184. van Ravenzwaay B., Cunha G.C.-P., Leibold E., Looser R., Mellert W., Prokoudine A., Walk T., and Wiemer J. The use of metabolomics for discovery of new biomarkers of effect. Toxicol. Lett. 172 (2007) 21-28
185. van Ravenzwaay B., and Leibold E. A comparison between in vitro rat and human and in vivo rat skin absorption. Hum. Exp. Toxicol. 23 (2004) 421-430
186. Vyskocil A., Drolet D., Viau C., Lemay F., Lapointe G., Tardif R., Truchon G., Baril M., Gagnon N., Gagnon F., Bégin D., and Gérin M. A web tool for the identification of potential interactive effects of chemical mixtures. J. Occup. Environ. Hyg. 4 (2007) 281-287
187. Winker R., and Rüdiger H.W. Reproductive toxicology in occupational settings: an update. Int. Arch. Occup. Environ. Health 79 (2006) 1-10
188. Xing X., Wu G., Wei F., Liu P., Wei H., Wang C., Xu J., Xun L., Jia J., Kennedy N., Elashoff D., and Robbins W. Biomarkers of environmental and workplace boron exposure. J. Occup. Environ. Hyg. 5 (2008) 141-147
189. Zielhuis R.L., and van der Kreek F.W. The use of a safety factor in setting health based permissible levels for occupational exposure. I. A proposal. Int. Arch. Occup. Environ. Health 42 (1979) 191-201
190. Zielhuis R.L., and van der Kreek F.W. Calculation of a safety factor in setting health based permissible levels for occupational exposure. II. Comparison of extrapolated and published permissible levels. Int. Arch. Occup. Environ. Health 42 (1979) 203-215
191. Zielhuis R.L., and Notten W.R.F. Permissible levels for occupational exposure: basic concepts. Int. Arch. Occup. Environ. Health 42 (1979) 269-281
192. Ziem G.E., and Castleman B.I. Threshold limit values: historical perspectives and current practice. J. Occup. Med. 31 (1989) 910-918